STOCKWATCH
·
Commodity Chemicals
Monthly Update30 Oct 2025, 11:11 pm

Fischer Medical Ventures Ltd Achieves INR 100 Crore Revenue, Secures New Geographies and Technology Rights

AI Summary

Fischer Medical Ventures Ltd, a leading innovator in the healthcare sector, has announced its latest corporate presentation. The company has achieved a significant milestone of INR 100 crore revenue in FY25. It has also secured new geographies including India, MENA, SEA, and other regions for its indigenously manufactured MRIs. The company has obtained new technologies from Columbia and Harvard universities. Fischer Medical Ventures Ltd has also secured distribution rights in India, APAC, and other regions. The company is addressing the chronic lack of MRIs in emerging markets, which presents a US$10B opportunity with an 8% CAGR over the next 5 years.

Key Highlights

  • Achieved INR 100 crore revenue in FY25
  • Secured new geographies for indigenously manufactured MRIs
  • Obtained new technologies from Columbia and Harvard universities
  • Secured distribution rights in India, APAC, and other regions
  • Addressing the US$10B opportunity in emerging markets with an 8% CAGR over the next 5 years
FISCHER
Commodity Chemicals
FISCHER CHEMIC LTD.

Price Impact